Amundi Asset Management US’s Novartis NVS Stock Holding History

Amundi Asset Management US’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,200	Closed	-$1.15M	–	1634
2020 Q2	$1.15M	Buy	+13,200	New	+$1.14M	﹤0.01%	1166
2018 Q2	–	Sell	-127,788	Closed	-$9.26M	–	1608
2018 Q1	$9.26M	Buy	+127,788	New	+$9.73M	0.01%	695
2017 Q4	–	Sell	-354,107	Closed	-$27.2M	–	1567
2017 Q3	$27.2M	Buy	354,107 +246,413	+229%	+$18.6M	0.09%	179
2017 Q2	$8.05M	Buy	+107,694	New	+$7.63M	0.03%	345
2015 Q3	–	Sell	-92,789	Closed	-$8.18M	–	628
2015 Q2	$8.18M	Buy	92,789 +226	+0.2%	+$20.7K	0.03%	372
2015 Q1	$8.18M	Hold	92,563	–	–	0.03%	374
2014 Q4	$7.68M	Sell	92,563 -3,973	-4%	-$329K	0.03%	375
2014 Q3	$8.14M	Buy	96,536 +200	+0.2%	+$16.2K	0.03%	368
2014 Q2	$7.82M	Buy	96,336 +1,030	+1%	+$81K	0.03%	391
2014 Q1	$7.26M	Hold	95,306	–	–	0.03%	394
2013 Q4	$6.86M	Hold	95,306	–	–	0.03%	400
2013 Q3	$6.55M	Hold	95,306	–	–	0.03%	418
2013 Q2	$6.04M	Buy	+95,306	New	+$6.2M	0.03%	419

Other funds holding NVS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Amundi Asset Management US's NVS Position: Q3 2020 in Review

Amundi Asset Management US sold out of Novartis (NVS) in Q3 2020, closing a stake of 13,200 shares — an estimated $1.15M sold.

Amundi Asset Management US first reported a position in NVS in Q2 2013 and held it in 13 quarters. The position peaked at $27.2M in Q3 2017. 1,118 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

Amundi Asset Management US reported no remaining Novartis position as of Q3 2020 after selling out during the quarter.
Amundi Asset Management US sold 13,200 Novartis shares in Q3 2020, an estimated $1.15M.
Amundi Asset Management US first reported a position in Novartis in Q2 2013 and held it in 13 quarters.
Amundi Asset Management US's Novartis position peaked at $27.2M in Q3 2017.
1,118 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on Amundi Asset Management US's 13F filing for Q3 2020, filed 16 Nov 2020.